1.The serum carbohydrate antigen 125 and carcinoembryonic antigen comparsion for the han and uyghur patients of terminal gallbladder cancer in xinjiang uygur autonomous region
Maimaiti MAOLAAISHA ; Feng XUE ; Abula YIMAMUMAIMAITIJIANG
Chinese Journal of Primary Medicine and Pharmacy 2013;20(3):362-364
Objective To compare the differences on the serum carbohydrate antigen 125 and carcinoembryonic antigen for the Han and Uyghur patients of terminal gallbladder cancer in Xinjiang Uygur Autonomous Region.Methods 80 cases of patients with primary advanced gallbladder,including 40 cases of Uighur,Han 40 cases,The cholecystitis patients randomly selected from the same period of hospitalization of 60 cases as the control group.Including 34 cases of Uighur and Han 26 cases,Levels of serum CA125,CEA were detected.Results The gallbladder group of Han,Uygur patients and the control group with ethnic patients CA125,CEA level differences were statistically significant(t =27.01,28.06,10.68,11.25,all P < 0.05) ; CA125,CEA level differences between the two groups within the Han,Uygur patients were not statistically significant(t =0.47,0.34,0.1 l,1.23,all P > 0.05) ; Han,Uygur patients with Stage V of gallbladder cancer stage Ⅳ with ethnic patients with CA125,CEA level differences were statistically significant (t =26.92,25.01,16.58,14.54,all P < 0.05) ; CA125,CEA levels between the Han,Uygur gallbladder patients with stage Ⅳ and Ⅴ patients,the differences were not statistically significant (t =1.13,0.11,0.38,0.07,all P > 0.05).Conclusion Xinjiang region of Han and Uygur advanced gallbladder serum CA125,CEA level differences in patients with advanced gallbladder CA125,CEA tests can help diagnose cases.
2.Prognostic significance of CUEDC2 expression in hepatocellular carcino-ma
Boqing WANG ; Feng XUE ; Wei DING ; Jianjun TANG ; Tiebang KANG ; Maolaaisha MAIMAITI ; Haijun LI ; Jintian TANG ; Xiaogang DONG ; Jiwei YIN ; Yimamumaimaitijiang ABULA ; Chao YI ; Lin XU ; Qing TONG ; Guoqing ZHANG
Chinese Journal of Pathophysiology 2015;(1):124-129
AIM:To investigate the expression of CUE domain-containing 2 (CUEDC2) in hepatocellular car-cinoma ( HCC) and to analyze its clinical prognostic significance .METHODS:Total 186 formalin-fixed paraffin-embed-ded tissues obtained from surgical HCC with detailed clinicopathological and follow -up data were used .The expression of CUEDC2 was detected by immunohistochemistry .The relationships between the expression of CUEDC 2 and clinicopatholog-ical characteristics and prognosis were analyzed .RESULTS: The positive rate of CUEDC 2 in HCC was 85.5% ( 159/186), among which, the low expression was 52.2%(97/186) and the high expression was 47.8%(89/186).CUEDC2 expression was correlated with serum alpha-fetal protein (AFP) level, tumor size, tumor number, tumor differentiation and TNM stage (P<0.05).Kaplan-Meier survival curves showed that the patients with high expression of CUEDC 2 were asso-ciated with significantly shorter overall survival and recurrence-free survival than those with low CUEDC 2 expression ( P<0.05).Multivariate Cox regression analysis revealed 3 independent prognostic factors including CUEDC 2 expression, ser-um AFP and tumor number .CONCLUSION:CUEDC2 was expressed in most HCC tissues , which was relevant to tumor growth, tumor differentiation and prognosis .CUEDC2 could be a novel valuable molecular marker to predict the HCC prog-nosis.